Neuroprotective effect of tafluprost in glaucoma treatment and its molecular mechanism

Journal Title: Eye Science (Yanke Xuebao) - Year 2024, Vol 39, Issue 6

Abstract

Glaucoma is characterized by the progressive degeneration and loss of retinal ganglion cells (RGC) and their axons, making it one of the most common causes of vision loss. Although the exact underlying mechanisms remain unclear, it is well known that elevated intraocular pressure (IOP) is a major risk factor for the progression of glaucoma. Currently, the primary means of controlling glaucoma involves reducing IOP through medication and surgery. Tafluprost, due to its effective and long-term ability to lower IOP, minimal side effects, high patient compliance, and absence of significant systemic side effects, has become the first-line treatment for primary open-angle glaucoma and ocular hypertension. Recent studies suggest that tafluprost may also have neuroprotective effects beyond its IOP-lowering effects. This article aims to review the pharmacological and potential neuroprotective effects of tafluprost, providing a theoretical basis and research foundation for developing more effective drugs for glaucoma treatment. However, there is still a lack of sufficient clinical evidence to support the neuroprotective effects of tafluprost, and further investigations are required to explore in this field to furnish critical theoretical backing for the development of drugs that target optic nerve protection and facilitate vision restoration through optic nerve regeneration.

Authors and Affiliations

Siting WU, Yiqing LI

Keywords

Related Articles

Application of inhaled sevoflurane via laryngeal mask airway in children undergoing outpatient fundus fluorescein angiography with general anesthesia

[Objective:] To observe the eye position, the incidence of eye movement and the efficacy of propofol on correcting eccentric eyeball position in children undergoing examination of outpatient fundus fluorescein angiograph...

Clinical distribution characteristics of patients admitted to hospital for surgical cataract treatment

[Objective:] To understand the clinical distribution characteristics of cataract surgery patients and provide reference for cataract prevention and treatment in primary hospitals. [Methods:] From January 2019 to December...

Risk factors for myopia progression in school-age children in Wenzhou, China

[Objective:] To investigate myopia progression and analyze the risk factors associated with myopia progression in a cohort of primary schoolchildren. [Methods:] The study was conducted in two primary schools in Wenzhou....

Ocular ischemia syndrome after autologous fat filling: a case report and fundus imaging features

Ocular ischemia syndrome (OIS), featuring as chronic ocular hypoperfusion, is an eye disease caused by a series of incentives. It is relatively rare in clinical practice, but has a great impact on vision. The symptoms of...

Differential effects of primary disease and corneal vascularisation on corneal transplant rejection and survival

[Objective:] To investigate the relative risk of pretransplant corneal vascularisation on rate of rejection and graft failure within 5 years of surgery when categorised by indication for transplantation. [Methods:] We an...

Download PDF file
  • EP ID EP761459
  • DOI 10.12419/24063003
  • Views 44
  • Downloads 0

How To Cite

Siting WU, Yiqing LI (2024). Neuroprotective effect of tafluprost in glaucoma treatment and its molecular mechanism. Eye Science (Yanke Xuebao), 39(6), -. https://europub.co.uk/articles/-A-761459